{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:52:35Z","timestamp":1778539955219,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.bpg.2019.02.003","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T17:21:38Z","timestamp":1550251298000},"page":"101601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["What is the role of histopathology in the evaluation of disease activity in Crohn's disease?"],"prefix":"10.1016","volume":"38-39","author":[{"given":"Rish K.","family":"Pai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vipul","family":"Jairath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bpg.2019.02.003_bib1","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.gie.2018.08.018","article-title":"The emerging role of histologic disease activity assessment in ulcerative colitis","volume":"88","author":"Pai","year":"2018","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"10.1016\/j.bpg.2019.02.003_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00428-017-2156-5","article-title":"Disease activity and mucosal healing in inflammatory bowel disease: a new role for histopathology?","volume":"472","author":"Pai","year":"2018","journal-title":"Virchows Arch"},{"issue":"12","key":"10.1016\/j.bpg.2019.02.003_bib3","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.dld.2017.08.041","article-title":"Acute histological inflammatory activity is associated with clinical relapse in patients with ulcerative colitis in clinical and endoscopic remission","volume":"49","author":"Calafat","year":"2017","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.bpg.2019.02.003_bib4","first-page":"55","article-title":"Association of endoscopic and histological remission with clinical course in patients of ulcerative colitis","volume":"16","author":"Narang","year":"2018","journal-title":"Int Res"},{"issue":"1","key":"10.1016\/j.bpg.2019.02.003_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/gast.2001.20912","article-title":"Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis","volume":"120","author":"Bitton","year":"2001","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.bpg.2019.02.003_bib6","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.cgh.2017.02.016","article-title":"Histologic normalization occurs in ulcerative colitis and is associated with improved clinical outcomes","volume":"15","author":"Christensen","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.bpg.2019.02.003_bib7","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/ajg.2016.418","article-title":"Histological disease activity as a predictor of clinical relapse among patients with ulcerative colitis: systematic review and meta-analysis","volume":"111","author":"Park","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.bpg.2019.02.003_bib8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ajg.2016.50","article-title":"Histology grade is independently associated with relapse risk in patients with ulcerative colitis in clinical remission: a prospective study","volume":"111","author":"Zenlea","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.bpg.2019.02.003_bib9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/gut.32.2.174","article-title":"Microscopic activity in ulcerative colitis: what does it mean?","volume":"32","author":"Riley","year":"1991","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.bpg.2019.02.003_bib10","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/ajg.2012.301","article-title":"Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing","volume":"107","author":"Bessissow","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.bpg.2019.02.003_bib11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/gutjnl-2015-309598","article-title":"Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up","volume":"65","author":"Bryant","year":"2016","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.bpg.2019.02.003_bib12","first-page":"1601","article-title":"Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study","volume":"11","author":"Rubin","year":"2013","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"17","key":"10.1016\/j.bpg.2019.02.003_bib13","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.3748\/wjg.v20.i17.4980","article-title":"Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis","volume":"20","author":"Korelitz","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.bpg.2019.02.003_bib14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1053\/j.gastro.2007.08.001","article-title":"Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study","volume":"133","author":"Gupta","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2019.02.003_bib15","unstructured":"Ulcerative Colitis: Clinical Trial Endpoints Guidance for Industry - UCM515143.pdf [Internet]. [cited 2017 Mar 15]. Available from: https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM515143.pdf."},{"issue":"6","key":"10.1016\/j.bpg.2019.02.003_bib16","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/ibd.21506","article-title":"Development of the Crohn's disease digestive damage score, the L\u00e9mann score","volume":"17","author":"Pariente","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"10080","key":"10.1016\/j.bpg.2019.02.003_bib17","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn's disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet Lond Engl"},{"issue":"11","key":"10.1016\/j.bpg.2019.02.003_bib18","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1136\/gutjnl-2012-302830","article-title":"Mucosal healing in inflammatory bowel diseases: a systematic review","volume":"61","author":"Neurath","year":"2012","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.bpg.2019.02.003_bib19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.gastro.2009.09.056","article-title":"Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease","volume":"138","author":"Baert","year":"2010","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bpg.2019.02.003_bib20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.gie.2005.08.011","article-title":"Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease","volume":"63","author":"Rutgeerts","year":"2006","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"10.1016\/j.bpg.2019.02.003_bib21","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1053\/j.gastro.2011.06.054","article-title":"Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis","volume":"141","author":"Colombel","year":"2011","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.bpg.2019.02.003_bib22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nrgastro.2016.128","article-title":"Current best practice for disease activity assessment in IBD","volume":"13","author":"Walsh","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.bpg.2019.02.003_bib23","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ajg.2015.233","article-title":"Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target","volume":"110","author":"Peyrin-Biroulet","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.bpg.2019.02.003_bib24","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.crohns.2012.10.018","article-title":"Achievement of deep remission during scheduled maintenance therapy with TNF\u03b1-blocking agents in IBD","volume":"7","author":"Molander","year":"2013","journal-title":"J\u00a0Crohns Colitis"},{"issue":"9","key":"10.1016\/j.bpg.2019.02.003_bib25","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/ibd.21925","article-title":"Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation","volume":"18","author":"Baars","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"10.1016\/j.bpg.2019.02.003_bib26","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1097\/MIB.0000000000001176","article-title":"Mucosal healing in clinical practice: a single-center pediatric IBD experience","volume":"23","author":"Santha","year":"2017","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.bpg.2019.02.003_bib27","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/MIB.0000000000000652","article-title":"Low fecal calprotectin correlates with histological remission and mucosal healing in ulcerative colitis and colonic Crohn's disease","volume":"22","author":"Zittan","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2019.02.003_bib28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jss.2017.02.064","article-title":"Correlation between fecal calprotectin and inflammation in the surgical specimen of Crohn's disease","volume":"213","author":"Pous-Serrano","year":"2017","journal-title":"J\u00a0Surg Res"},{"issue":"2","key":"10.1016\/j.bpg.2019.02.003_bib29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/jcp.30.2.126","article-title":"Rectal biopsy as a prognostic guide in Crohn's colitis","volume":"30","author":"Ward","year":"1977","journal-title":"J\u00a0Clin Pathol"},{"issue":"1","key":"10.1016\/j.bpg.2019.02.003_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MCG.0000000000000507","article-title":"Clinical implications of histologic abnormalities in ileocolonic biopsies of patients with Crohn's disease in remission","volume":"51","author":"Brennan","year":"2017","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.bpg.2019.02.003_bib31","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.gie.2017.10.033","article-title":"Prediction of clinical outcomes in Crohn's disease by using confocal laser endomicroscopy: results from a prospective multicenter study","volume":"87","author":"Tontini","year":"2018","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"10.1016\/j.bpg.2019.02.003_bib32","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.cgh.2017.12.034","article-title":"Epithelioid granulomas associate with increased severity and progression of Crohn's disease, based on 6-year follow-up","volume":"16","author":"Johnson","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.bpg.2019.02.003_bib33","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3109\/00365521.2014.920911","article-title":"Pediatric Crohn's disease from onset to adulthood: granulomas are associated with an early need for immunomodulation","volume":"49","author":"Idestr\u00f6m","year":"2014","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.bpg.2019.02.003_bib34","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/MIB.0000000000000224","article-title":"Histologic features predicting postoperative Crohn's disease recurrence","volume":"21","author":"Bressenot","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"10.1016\/j.bpg.2019.02.003_bib35","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/BF02049707","article-title":"Do microscopic abnormalities at resection margins correlate with increased anastomotic recurrence in Crohn's disease? Retrospective analysis of 100 cases","volume":"34","author":"Kotanagi","year":"1991","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"10.1016\/j.bpg.2019.02.003_bib36","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00000658-199610000-00014","article-title":"Effect of resection margins on the recurrence of Crohn's disease in the small bowel. A randomized controlled trial","volume":"224","author":"Fazio","year":"1996","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.bpg.2019.02.003_bib37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF02562486","article-title":"The importance of disease-free margins in resections for Crohn's disease","volume":"26","author":"Wolff","year":"1983","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"10.1016\/j.bpg.2019.02.003_bib38","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1053\/j.gastro.2006.02.025","article-title":"The value of myenteric plexitis to predict early postoperative Crohn's disease recurrence","volume":"130","author":"Ferrante","year":"2006","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.bpg.2019.02.003_bib39","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/gut.2009.177782","article-title":"Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease","volume":"58","author":"Sokol","year":"2009","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.bpg.2019.02.003_bib40","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1097\/MIB.0b013e318281f336","article-title":"Submucosal plexitis as a predictor of postoperative surgical recurrence in Crohn's disease","volume":"19","author":"Bressenot","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.bpg.2019.02.003_bib41","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/codi.12896","article-title":"Myenteric plexitis at the proximal resection margin is a predictive marker for surgical recurrence of ileocaecal Crohn's disease","volume":"17","author":"Misteli","year":"2015","journal-title":"Colorectal Dis"},{"issue":"2","key":"10.1016\/j.bpg.2019.02.003_bib42","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/ecco-jcc\/jjw135","article-title":"Submucosal plexitis as a predictive factor for postoperative endoscopic recurrence in patients with Crohn's disease undergoing a resection with ileocolonic anastomosis: results from a prospective single-centre study","volume":"11","author":"Lemmens","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"issue":"1","key":"10.1016\/j.bpg.2019.02.003_bib43","first-page":"78","article-title":"Presence of granulomas is associated with recurrence after surgery for Crohn's disease: experience of a surgical unit","volume":"84","author":"Anseline","year":"1997","journal-title":"Br J Surg"},{"issue":"10","key":"10.1016\/j.bpg.2019.02.003_bib44","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/j.1463-1318.2010.02421.x","article-title":"Granulomas in Crohn's disease: does progression through the bowel layers affect presentation or predict recurrence?","volume":"13","author":"Denoya","year":"2011","journal-title":"Colorectal Dis"},{"issue":"2","key":"10.1016\/j.bpg.2019.02.003_bib45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0016-5085(82)80336-3","article-title":"Granulomas do not affect postoperative recurrence rates in Crohn's disease","volume":"83","author":"Wolfson","year":"1982","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.bpg.2019.02.003_bib46","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1097\/MIB.0b013e3182971cec","article-title":"Decreased lymphatic vessel density is associated with postoperative endoscopic recurrence in Crohn's disease","volume":"19","author":"Rahier","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.bpg.2019.02.003_bib47","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/j.gastro.2013.09.048","article-title":"Genetic variants synthesize to produce paneth cell phenotypes that define subtypes of Crohn's disease","volume":"146","author":"VanDussen","year":"2014","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.bpg.2019.02.003_bib48","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.cgh.2018.02.051","article-title":"Heterogeneity in definitions of efficacy and safety endpoints for clinical trials of Crohn's disease: a systematic review","volume":"16","author":"Ma","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.bpg.2019.02.003_bib49","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ibd.20777","article-title":"Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease","volume":"15","author":"Mantzaris","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.bpg.2019.02.003_bib50","first-page":"425","article-title":"Characterisation of mucosal healing with adalimumab treatment in patients with moderately to severely active Crohn's disease: results from the EXTEND trial","volume":"11","author":"Reinisch","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"issue":"10066","key":"10.1016\/j.bpg.2019.02.003_bib51","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0140-6736(16)32537-5","article-title":"Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial","volume":"389","author":"Vermeire","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bpg.2019.02.003_bib52","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MIB.0000000000000689","article-title":"Higher adalimumab levels are associated with histologic and endoscopic remission in patients with Crohn's disease and ulcerative colitis","volume":"22","author":"Yarur","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2019.02.003_bib53","doi-asserted-by":"crossref","DOI":"10.1007\/s10620-018-5202-5","article-title":"Maintenance adalimumab concentrations are associated with biochemical, endoscopic, and histologic remission in inflammatory bowel disease","author":"Juncadella","year":"2018","journal-title":"Dig Dis Sci"},{"issue":"10","key":"10.1016\/j.bpg.2019.02.003_bib54","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1093\/ibd\/izy132","article-title":"Association between serum infliximab trough concentrations during maintenance therapy and biochemical, endoscopic, and histologic remission in Crohn's disease","volume":"24","author":"Papamichael","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2019.02.003_bib55","first-page":"CD012351","article-title":"Histologic scoring indices for evaluation of disease activity in Crohn's disease","volume":"7","author":"Novak","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.bpg.2019.02.003_bib56","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0016-5085(98)70476-7","article-title":"Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum","volume":"114","author":"D'Haens","year":"1998","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bpg.2019.02.003_bib57","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-2036.2003.01487.x","article-title":"Response, relapse and mucosal immune regulation after infliximab treatment in fistulating Crohn's disease","volume":"17","author":"Agnholt","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.bpg.2019.02.003_bib58","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1365-2036.2008.03835.x","article-title":"Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings","volume":"28","author":"Sipponen","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.bpg.2019.02.003_bib59","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1185\/030079905X65457","article-title":"Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn's disease","volume":"21","author":"Geboes","year":"2005","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"10.1016\/j.bpg.2019.02.003_bib60","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.humpath.2012.03.008","article-title":"A\u00a0histopathologic scoring system as a tool for standardized reporting of chronic (ileo)colitis and independent risk assessment for inflammatory bowel disease","volume":"43","author":"Naini","year":"2012","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.bpg.2019.02.003_bib61","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/gutjnl-2015-310393","article-title":"Development and validation of a histological index for UC","volume":"66","author":"Mosli","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2019.02.003_bib62","article-title":"Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial","author":"Jairath","year":"2018","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bpg.2019.02.003_bib63","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gutjnl-2015-310187","article-title":"Development and validation of the Nancy histological index for UC","volume":"66","author":"Marchal-Bressenot","year":"2017","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.bpg.2019.02.003_bib64","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.crohns.2014.08.011","article-title":"Systematic review: histological remission in inflammatory bowel disease. Is \u201ccomplete\u201d remission the new treatment paradigm? An IOIBD initiative","volume":"8","author":"Bryant","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"issue":"3","key":"10.1016\/j.bpg.2019.02.003_bib65","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00428-018-2405-2","article-title":"Eosinophils in the gastrointestinal tract: how much is normal?","volume":"473","author":"Silva","year":"2018","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.bpg.2019.02.003_bib66","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/PAS.0000000000000760","article-title":"Primary colonic eosinophilia and eosinophilic colitis in adults","volume":"41","author":"Turner","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.bpg.2019.02.003_bib67","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/his.13228","article-title":"The pathology and causes of tissue eosinophilia in the gastrointestinal tract","volume":"71","author":"Conner","year":"2017","journal-title":"Histopathology"},{"issue":"11","key":"10.1016\/j.bpg.2019.02.003_bib68","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1136\/gutjnl-2014-307536","article-title":"Reproducibility of histological assessments of disease activity in UC","volume":"64","author":"Mosli","year":"2015","journal-title":"Gut"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691819300058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691819300058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:01:33Z","timestamp":1761498093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691819300058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":68,"alternative-id":["S1521691819300058"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2019.02.003","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What is the role of histopathology in the evaluation of disease activity in Crohn's disease?","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2019.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101601"}}